The pro-inflammatory microenvironment promoted by TLR3 activation of NF-κB may also be a prognostic risk factor in cancer progression, as observed in many cancers, such as head and neck squamous cell carcinoma, colon carcinoma, and hepatocellular carcinoma [43–45]. Here, TLR3 is linked to cancer.